Spina Bifida In-Utero Market Report 2026

Spina Bifida In-Utero Market Overview

• Spina Bifida In-Utero market size has reached to $2.65 billion in 2025 • Expected to grow to $4.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Expansion Of Healthcare Facilities Driving The Growth Of The Market Due To Advancements In Medical Technology • Market Trend: Innovative Surgery Centers Revolutionizing Spina Bifida In Utero Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Spina Bifida In-Utero Market?

Spina bifida in-utero refers to a prenatal surgical procedure performed to repair spina bifida, a neural tube defect where the spine and spinal cord don’t develop properly. The surgery, done before birth, aims to reduce complications such as hydrocephalus and improve mobility and neurological outcomes. It helps protect the exposed spinal cord from further damage by closing the defect earlier. This intervention can enhance the child's quality of life compared to postnatal repair. The main types of spina bifida in-utero are myelomeningocele, meningocele, occulta. Myelomeningocele is the most severe form of spina bifida, where the spinal cord and meninges protrude through an opening in the spine. The various diagnosis include ultrasound, magnetic resonance imaging (MRI), amniocentesis. The various treatment include surgery, postnatal surgery, medication management. These are also used by various end-users such as hospitals, specialty clinics, ambulatory surgical centers.

What Is The Spina Bifida In-Utero Market Growth Forecast?

The spina bifida in-utero market size is expected to see strong growth in the next few years. It will grow to $4.06 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to minimally invasive fetal surgery adoption, improved surgical success rates, expansion of maternal-fetal centers, technological innovation in instruments, clinical guideline evolution. Major trends in the forecast period include fetal surgery technique refinement, early prenatal screening adoption, multidisciplinary fetal care teams, specialized surgical instruments, improved maternal-fetal outcomes.

Global Spina Bifida In-Utero Market Segmentation

1) By Type: Myelomeningocele, Meningocele, Occulta 2) By Diagnosis: Ultrasound, Magnetic Resonance Imaging (MRI), Amniocentesis 3) By Treatment: Surgery, Postnatal Surgery, Medication Management 4) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Subsegments: 1) By Myelomeningocele: Open Myelomeningocele, Closed Myelomeningocele, Lumbosacral Myelomeningocele, Thoracic Myelomeningocele, Cervical Myelomeningocele 2) By Meningocele: Cranial Meningocele, Spinal Meningocele, Occipital Meningocele, Frontal Meningocele, Parietal Meningocele 3) By Occulta: Lumbosacral Spina Bifida Occulta, Sacral Spina Bifida Occulta, Isolated Spina Bifida Occulta, Complex Spina Bifida Occulta, Tethered Cord Syndrome Associated Occulta

What Is The Driver Of The Spina Bifida In-Utero Market?

The rising healthcare facilities is expected to propel the growth of the spina bifid in-utero market going forward. Healthcare facilities refer to the essential physical facilities, systems, and resources needed to provide effective healthcare services. Expanding healthcare infrastructure is due to advancements in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics require upgraded facilities, specialized equipment, and enhanced healthcare delivery systems to improve patient outcomes and efficiency. Healthcare facilities support spina bifida in-utero by ensuring access to evidence-based therapies, trained medical professionals, and innovative treatment options, all of which contribute to improved healing outcomes and better patient quality of life. For instance, in Jamuary 2024, according to the American Hospital Association, a US-based non-profit organization, in 2024, the United States had 6,120 hospitals. Therefore, the expanding healthcare infrastructure is driving the growth of the spina bifida in-utero industry.

Key Players In The Global Spina Bifida In-Utero Market

Major companies operating in the spina bifida in-utero market are Mayo Clinic, GE HealthCare, UC San Francisco, Children’s Health, Memorial Hermann Health System, Oregon Health & Science University, Seattle Children's, Texas Children’s, Children's Hospital of Philadelphia, UW Health, UC Davis, UCSF Health, Burjeel Hospital, UT Physicians, Riley Children's Health, Yale Medicine, Focused Ultrasound Foundation, Boston Children’s Hospital, Johns Hopkins Hospital, Cleveland Clinic, Mount Sinai Health System, Stanford Health Care

Global Spina Bifida In-Utero Market Trends and Insights

Major companies operating in the spina bifida in utero market are establishing innovative centers, such as surgery centers, to integrate advanced imaging and minimally invasive techniques for fetal interventions. A surgery center refers to a specialized facility where surgical procedures are performed on an outpatient basis, eliminating the need for hospital admission. For instance, in January 2025, Wadia Hospital, an India-based healthcare institution, launched a center offering fetal surgery for open spina bifida. The new facility integrates cutting-edge surgical techniques with a multidisciplinary approach, enabling early intervention that can reduce complications and improve long-term outcomes for affected infants. This center focus on enhancing surgical precision and patient care, promising development for families facing the challenges of open spina bifida.

What Are Latest Mergers And Acquisitions In The Spina Bifida In-Utero Market?

In March 2024, Lilavati Hospital, an India-based multi-specialty healthcare institution, partnered with the Medical University of Silesia. The partnership aims to establish a fetal surgery department to provide advanced in-utero treatment for birth defects such as Spina Bifida, enhancing prenatal healthcare and patient outcomes. Medical University of Silesia is a Poland-based medical institution that provides advanced fetal surgery techniques and in utero treatment for conditions.

Regional Outlook

North America was the largest region in the spina bifida in utero market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Spina Bifida In-Utero Market?

The spina bifida in-utero market consists of revenues earned by entities providing services such as physical therapy planning, genetic counseling, and multidisciplinary team support. The market value includes the value of related goods sold by the service provider or included within the service offering. The spina bifida in-utero market also includes sales of sales of anesthesia and maternal support equipment, fetal monitoring devices, and biodegradable adhesives and sealants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Spina Bifida In-Utero Market Report 2026?

The spina bifida in-utero market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the spina bifida in-utero industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.